Literature DB >> 19548123

Leukocyte immunoglobulin-like receptors as new players in autoimmunity.

Rachel Thomas1, Torsten Matthias, Torsten Witte.   

Abstract

Leukocyte immunoglobulin-like receptors (LILR) are a family of at least 13 receptors mainly expressed on lymphoid and myelomonocytic cells. They are involved in the activation of the immune system. Inhibitory LILR (termed LILRB) signal through immunoreceptor tyrosine-based inhibitory motives in the cytoplasmic domain, whereas LILRA with short cytoplasmic domains are stimulatory receptors. Polymorphisms and deletions of leukocyte immunoglobulin-like receptors have been shown to be associated with autoimmune disorders, and some of the receptors are involved in the generation of regulatory T cells. Therefore, leukocyte immunoglobulin-like receptors may be central in the pathogenesis of autoimmunity. The data linking these receptors to autoimmune diseases is reviewed here.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19548123     DOI: 10.1007/s12016-009-8148-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  15 in total

1.  Association of multiple sclerosis with ILT6 deficiency.

Authors:  S Koch; R Goedde; V Nigmatova; J T Epplen; N Müller; J de Seze; P Vermersch; T Momot; R E Schmidt; T Witte
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

2.  Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.

Authors:  Sophie Lefebvre; Martine Antoine; Serge Uzan; Michael McMaster; Jean Dausset; Edgardo D Carosella; Pascale Paul
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

3.  Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice.

Authors:  Azusa Ujike; Kazuhiko Takeda; Akira Nakamura; Shin Ebihara; Kenichi Akiyama; Toshiyuki Takai
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

4.  Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4.

Authors:  C C Chang; R Ciubotariu; J S Manavalan; J Yuan; A I Colovai; F Piazza; S Lederman; M Colonna; R Cortesini; R Dalla-Favera; N Suciu-Foca
Journal:  Nat Immunol       Date:  2002-01-28       Impact factor: 25.606

5.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Authors:  Mitsunori Shiroishi; Kouhei Tsumoto; Kimie Amano; Yasuo Shirakihara; Marco Colonna; Veronique M Braud; David S J Allan; Azure Makadzange; Sarah Rowland-Jones; Benjamin Willcox; E Yvonne Jones; P Anton van der Merwe; Izumi Kumagai; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

6.  Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells.

Authors:  Seunghee Kim-Schulze; Luigi Scotto; George Vlad; Flavia Piazza; Hana Lin; Zhuoru Liu; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

7.  Evidence for natural selection on leukocyte immunoglobulin-like receptors for HLA class I in Northeast Asians.

Authors:  Kouyuki Hirayasu; Jun Ohashi; Hidenori Tanaka; Koichi Kashiwase; Atsuko Ogawa; Minoko Takanashi; Masahiro Satake; Guan Jun Jia; Nyam-Osor Chimge; Elena W Sideltseva; Katsushi Tokunaga; Toshio Yabe
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

8.  Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.

Authors:  Nicole Suciu-Foca; Nikki Feirt; Qing-Yin Zhang; George Vlad; Zhuoru Liu; Hana Lin; Chih-Chao Chang; Eric K Ho; Adriana I Colovai; Howard Kaufman; Vivette D D'Agati; Harshwardhan M Thaker; Helen Remotti; Sara Galluzzo; Paola Cinti; Carla Rabitti; John Allendorf; John Chabot; Marco Caricato; Roberto Coppola; Pasquale Berloco; Raffaello Cortesini
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 9.  Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.

Authors:  Michael P Pender
Journal:  Autoimmun Rev       Date:  2009-01-30       Impact factor: 9.754

10.  A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing.

Authors:  M Cella; C Döhring; J Samaridis; M Dessing; M Brockhaus; A Lanzavecchia; M Colonna
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

View more
  12 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Expression Profiling of Inflammatory and Immunological Genes in Collagenous Colitis.

Authors:  Qingqing Liu; Noam Harpaz
Journal:  J Crohns Colitis       Date:  2019-05-27       Impact factor: 9.071

3.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterations.

Authors:  Noweeda Mirza; Kevin Pollock; Dominique B Hoelzinger; Ana Lucia Dominguez; Joseph Lustgarten
Journal:  Aging Cell       Date:  2011-08-07       Impact factor: 9.304

5.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

6.  LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.

Authors:  Myongchol Ryu; Yong Chen; Jianxun Qi; Jun Liu; Zheng Fan; Gol Nam; Yi Shi; Hao Cheng; George F Gao
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Systems biology of vaccination for seasonal influenza in humans.

Authors:  Helder I Nakaya; Jens Wrammert; Eva K Lee; Luigi Racioppi; Stephanie Marie-Kunze; W Nicholas Haining; Anthony R Means; Sudhir P Kasturi; Nooruddin Khan; Gui-Mei Li; Megan McCausland; Vibhu Kanchan; Kenneth E Kokko; Shuzhao Li; Rivka Elbein; Aneesh K Mehta; Alan Aderem; Kanta Subbarao; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2011-07-10       Impact factor: 25.606

8.  Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.

Authors:  Miguel A Ortiz; Concepción Núñez; David Ordóñez; José C Alvarez-Cermeño; José E Martínez-Rodriguez; Antonio J Sánchez; Rafael Arroyo; Guillermo Izquierdo; Sunny Malhotra; Xavier Montalban; Antonio García-Merino; Elvira Munteis; Antonio Alcina; Manuel Comabella; Fuencisla Matesanz; Luisa M Villar; Elena Urcelay
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 9.  HLA-dependent tumour development: a role for tumour associate macrophages?

Authors:  Maddalena Marchesi; Emilia Andersson; Lisa Villabona; Barbara Seliger; Andreas Lundqvist; Rolf Kiessling; Giuseppe V Masucci
Journal:  J Transl Med       Date:  2013-10-06       Impact factor: 5.531

10.  LILRA6 copy number variation correlates with susceptibility to atopic dermatitis.

Authors:  M R López-Álvarez; W Jiang; D C Jones; J Jayaraman; C Johnson; W O Cookson; M F Moffatt; J Trowsdale; J A Traherne
Journal:  Immunogenetics       Date:  2016-06-22       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.